n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with b 43 in 3 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (b 43) | Trials (b 43) | Recent Studies (post-2010) (b 43) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 29 | 0 | 17 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | b 43 (IC50) |
|---|---|---|---|
| Chain A, Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.0007 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 1.6885 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.1703 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.126 | |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.42 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 0.315 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2.5267 | |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | 5.18 | |
| Angiopoietin-1 receptor | Homo sapiens (human) | 4.3433 | |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.31 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
3 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and b 43
| Article | Year |
|---|---|
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |